Voyager Therapeutics

Voyager Therapeutics

Focus:

Type: Public Corporation
Founded: 2014


Leadership
Michael Higgins
CEO


Financial Performance



Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2014
45M USD
Series A
2015
30M USD
Corporate Equity
2015
Equity
/ 60.0M USD
60M USD
Series B
2015
70M USD
Post-IPO Equity
Known Investors
Name
Type
HQ
Other Relevant Investments
Asset Management
United States
Venture Capital
United States
Venture Capital
United States
Corporation
United States
Venture Capital
United States
Investment Bank
United States
*More data available at: [CB Insights] [CrunchBase] [PitchBook]

Related
News